Engineers Gate Manager’s Janux Therapeutics JANX Stock Holding History

Engineers Gate Manager’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Sell	45,313 -6,508	-13%	-$94.3K	0.01%	1295
2026 Q1	$720K	Buy	51,821 +38,674	+294%	+$530K	0.01%	1211
2025 Q4	$181K	Buy	13,147 +4,231	+47%	+$99.5K	﹤0.01%	1823
2025 Q3	$218K	Sell	8,916 -30,833	-78%	-$751K	﹤0.01%	1870
2025 Q2	$918K	Buy	39,749 +21,258	+115%	+$560K	0.01%	1164
2025 Q1	$499K	Buy	18,491 +13,139	+245%	+$495K	0.01%	1456
2024 Q4	$287K	Buy	+5,352	New	+$283K	0.01%	1720
2024 Q3	–	Sell	-7,023	Closed	-$294K	–	2248
2024 Q2	$294K	Buy	+7,023	New	+$330K	0.01%	1480

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Engineers Gate Manager's JANX Position: Q2 2026 in Review

Engineers Gate Manager reduced its Janux Therapeutics (JANX) stake by 13% in Q2 2026, selling an estimated $94.3K and leaving 45,313 shares worth $696K. The position accounts for 0.01% of the portfolio, ranked #1295.

Engineers Gate Manager first reported a position in JANX in Q2 2024 and has held it in 8 quarters since. The position peaked at $918K in Q2 2025. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Engineers Gate Manager held 45,313 shares of Janux Therapeutics worth $696K as of Q2 2026.
Engineers Gate Manager sold 6,508 Janux Therapeutics shares in Q2 2026, an estimated $94.3K.
Janux Therapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1295 holding.
Engineers Gate Manager first reported a position in Janux Therapeutics in Q2 2024 and has held it in 8 quarters since.
Engineers Gate Manager's Janux Therapeutics position peaked at $918K in Q2 2025.
198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.